跳至主要内容
临床试验/NCT01065857
NCT01065857已完成3 期

Phase III, Multicenter, Randomized, Assessor-blind Study to Evaluate the Safety and Efficacy of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.

Laboratorios Casen-Fleet S.L.U.15 个研究点 分布在 1 个国家目标入组 547 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
547
试验地点
15
主要终点
Percentage of subjects that achieve 'excellent' or 'good' cleansing in the Fleet® Grading Scale for Bowel Cleansing.

研究概览

简要总结

The purpose of this study is to determine any significant differences in the efficacy and acceptability between CitraFleet and Klean Prep® (polyethylene glycol) for the preparation of gastrointestinal subjects undergoing a colon examination.

详细描述

The composite principal objective of the current study will therefore be, to determine any significant differences in the joint variable of efficacy and acceptability between CitraFleet and Klean Prep® (polyethylene glycol) for the preparation of subjects undergoing a colon examination.

The evaluation will be carried out by two blinded assessors, independent of the investigator who performed the procedure (endoscopist investigator). It will be assessed from images of different sections of the colon: cecum, ascending, transverse, descending and rectum and subsequent confirmation by Principal Investigator if an agreement has been reached between the two blinded assessors or whether it is necessary to reach consensus.

The evaluation of the subject's acceptability will be assessed using a 5 point scale which assesses the difficulty of taking the product, the degree of discomfort caused by it, and the taste of the drug.

The secondary objective is to evaluate the safety of CitraFleet.

In addition a second exploratory arm of CitraFleet was included in this study (CitraFleet Exploratory arm). The study is not powered to make formal statistical comparisons for this arm. Exploratory assessment of this arm against the main CitraFleet regimen and Klean-Prep will be made in order to run future trials design with this schedule.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are between 18 and 80 years of age.
  • Subjects undergoing complete colonoscopy and therefore require prior preparation with either Klean Prep® or CitraFleet.
  • Subjects capable of maintaining appropriate oral hydration during the intestinal preparation process.
  • Subjects that have provided written informed consent.
  • Subjects in whom the use of any of the study drugs (KleanPrep®,CitraFleet) is not contraindicated.
  • Subjects who can communicate with the study personnel and comply with study requirements.
  • Subjects undergoing a complete exploratory diagnostic colonoscopy for the first time.

排除标准

  • Severe renal insufficiency.
  • Congestive heart failure.
  • Gastrointestinal obstruction, gastric retention, intestinal perforation and/or ileus.
  • Megacolon and/or toxic colitis.
  • Nausea and/or vomiting and/or abdominal pain.
  • Severe dehydration.
  • Hypermagnesemia.
  • Rhabdomyolysis.
  • Pregnant women.
  • Subjects who have participated in a clinical trial in the previous 30 days.
  • Abdominal surgery for any acute process (for example acute appendicitis).
  • Active inflammatory intestinal disease.
  • Known allergy to any of the active ingredients or excipients of the study drugs.
  • Subjects not providing written informed consent.
  • Subjects not complying with all of the inclusion criteria.

研究组 & 干预措施

Citrafleet

Experimental

The day prior to the colonoscopy in two dose times, first at 15:00h and second at 20:00h.

干预措施: Sodium picosulphate, light magnesium oxide and anhydride citric acid. (Drug)

Klean Prep

Active Comparator

The day prior to the colonoscopy from 16:00h to 20:00h.

干预措施: Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate. (Drug)

Citrafleet Exploratory

Experimental

The day of the colonoscopy in two dose times, first at 06:00h and second at 09:00h.

干预措施: Sodium picosulphate, light magnesium oxide and anhydride citric acid. (Drug)

结局指标

主要结局

Percentage of subjects that achieve 'excellent' or 'good' cleansing in the Fleet® Grading Scale for Bowel Cleansing.

时间窗: 24 hours

Percentage of subjects who find the agent easy to take or tolerable using a 5 point scale which assesses, the difficulty of taking the product, the degree of discomfort caused by it, and the taste of the drug, recorded in the subject questionnaire

时间窗: 24 hours

次要结局

  • Frequency of adverse reactions.(24 hours)

研究者

申办方类型
Industry

研究点 (15)

Loading locations...

相似试验